NSC |
Compound |
Enrichment |
Correlation |
NSC 701022 |
Null |
0.0392716453377535 |
0.26192761 |
NSC 701023 |
Aceanthryleno[1,2-b]quinoxaline, 12-nitro- |
0.0392716453377535 |
0.04105075 |
NSC 706992 |
Null |
0.0392716453377535 |
-0.019694819 |
NSC 709974 |
Null |
0.0392716453377535 |
0.42274122 |
NSC 715481 |
Null |
0.0392716453377535 |
0.031785533 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0392716453377535 |
0.2007453 |
NSC 726217 |
Combretastatin A4-analogue |
0.0392716453377535 |
0.10813718 |
NSC 726442 |
4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride |
0.0392716453377535 |
0.30222378 |
NSC 727620 |
6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride |
0.0392716453377535 |
0.22943413 |
NSC 732205 |
Null |
0.0392716453377535 |
0.47888336 |